CN102133380B - Medicament for treating cervical spondylosis - Google Patents
Medicament for treating cervical spondylosis Download PDFInfo
- Publication number
- CN102133380B CN102133380B CN2011100844336A CN201110084433A CN102133380B CN 102133380 B CN102133380 B CN 102133380B CN 2011100844336 A CN2011100844336 A CN 2011100844336A CN 201110084433 A CN201110084433 A CN 201110084433A CN 102133380 B CN102133380 B CN 102133380B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicament
- cervical spondylosis
- treating
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of medicaments and particularly relates to a medicament for treating cervical spondylosis. The invention provides a medicament which has an obvious effect and small toxic and side effects and is used for treating cervical spondylosis. The medicament is used for treating numb, pain, limitation of activity and the like in limbs caused by cervical vertebra osteoproliferation and cervical spondylosis, and is prepared from the following raw material medicaments in part by weight: 15 parts of astragalus, 10 parts of liquoric root, 10 parts of bupleurum, 10 parts of ephedra, 10 parts of szechuan lovage rhizome, 5 parts of suberect spatholobus stem, 5 parts of safflower, 5 parts of bunge auriculate root and 5 parts of curcuma aromatica. The invention has the advantages that: the medicament has the effects of relaxing tendons and removing obstruction in channels and relieving spasm and pain, is used for treating the numb, pain and limitation of activity in limbs caused by the cervical vertebra osteoproliferation and the cervical spondylosis, and has an obvious effect; and the raw material medicaments in the medicament are traditional Chinese medicaments, and do not have toxic or side effect, so the medicament can be taken safely.
Description
Technical field
The invention belongs to medical technical field, be specifically related to a kind of medicine of treating cervical spondylosis.
Background technology
Cervical spondylosis is the root of multiple disease, and along with modern society's rhythm of life is accelerated, working method changes; Computer, air-conditioning extensive use; People suffer the wind-cold damp pathogen invasion and attack and bend the neck probability to increase considerably, and cause the cervical spondylosis sickness rate constantly to rise, and age of onset constantly shift to an earlier date.
Cervical spondylosis is claimed cervical spine syndrome again, is the general name that osteoarthritis of cervical spine, proliferative cervical spondylosis, cervical syndrome, cervical intervertebral disk are deviate from disease, is a kind of illness of changing into the basis with degeneration pathology.Mainly due to cervical vertebra strain for a long time, hyperosteogeny, or prolapse of intervertebral disc, ligament thicken, and causes cervical vertebra spinal cord, nerve root or vertebral artery pressurized, causes a series of handicapped clinical syndromes.Show as intervertebral disc degradation itself and insecondary a series of pathological change thereof, like vertebra joint unstability, loosening; Vertebral pulp is given prominence to or is deviate from; Bony spur forms; The spinal canal stenosis of ligament plumpness and secondary etc. stimulate or have oppressed the tissues such as nerve root, spinal cord, vertebral artery and cervical region sympathetic nerve of vicinity, and cause the syndrome of various sings and symptoms.
To cervical spondylosis, multiple therapy is arranged at present.Physiotherapy has the traction treatment that utilizes various machineries, massotherapy, thermotherapy, magnetic therapy etc., and effect is not ideal enough, and mostly the medicine of treatment hyperosteogeny is medicine for external use, generally can only relief of symptoms, though oral medicine is also arranged, toxicity is big, should not obey for a long time.So, pressing for determined curative effect, toxic and side effects is little, is suitable for the medicine of taking for a long time.
Summary of the invention
The invention provides the medicine of the treatment cervical spondylosis that a kind of effect is remarkable, toxic and side effects is little, be used for numb limbs and tense tendons, pain that hyperosteogeny of cervical vertebra, cervical spondylosis cause, limitation of activity etc.
The traditional Chinese medical science thinks how weak with age hyperosteogeny is, qi depression to blood stasis, and the damp and hot expectorant stasis of blood hinders in the passages through which vital energy circulates joint, due to QI and blood is not smooth, with nourshing blood and promoting blood circulation, the kidney tonifying circulation of qi promoting, dispelling wind and removing obstruction in the collateral, removing damp and stopping pain are the Therapeutic Principle.The present invention is based on pathogeny " all kinds of diseases and ailments all be born in expectorant; all kinds of diseases and ailments all be born in the stasis of blood ", " institute of heresy gather; its gas must empty ", " pain then obstructed " of the traditional Chinese medical science to cervical spondylosis; Select that blood circulation promoting and blood stasis dispelling, nourishing and enriching blood, collateral dredging are active for use, expelling wind and cold, reduce phlegm and win wet, nourishing the liver and kidney, strong muscles and bones, the antiinflammatory bullate medicine of dispelling, with strengthening vital QI to eliminate pathogenic factors, strong positive bone strengthening, dissipating blood stasis antiinflammatory, improve blood circulation, suppress to eliminate edema, thereby reach the purpose of treatment cervical spondylosis.
The present invention treats the medicine of cervical spondylosis and gropes in a large number to sum up to draw through the inventor, is to be processed by following bulk drugs: 15 parts of the Radixs Astragali, 10 parts in Radix Glycyrrhizae; 10 parts of Radix Bupleuri, 10 parts in Herba Ephedrae, 10 parts of Rhizoma Chuanxiongs; 5 parts of Caulis Spatholobis, 5 parts on Flos Carthami, 5 parts of Radix Cynanchi Auriculatis, 5 parts of Radix Curcumaes.
The Radix Astragali: invigorating QI to consolidate the body surface resistance, diuresis poison holding.
Radix Glycyrrhizae: heat-clearing and toxic substances removing, expelling phlegm for arresting cough.
Radix Bupleuri: reducing fever by reconciliation, dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy.
Herba Ephedrae: diaphoresis, relieving asthma, diuretic.
Rhizoma Chuanxiong: blood-activating and qi-promoting, activating QI to alleviate the depression, wind-expelling pain-stopping.
Caulis Spatholobi: enrich blood, invigorate blood circulation, collateral dredging.Be used for blood deficiency and yellow complexion, paralysis and numbness, rheumatic arthralgia.
Flos Carthami: be used for promoting blood circulation to restore menstrual flow, the blood stasis removing pain relieving.
Radix Cynanchi Auriculati: strengthening by means of tonics, nourish blood and enrich blood, crow palpus hair color, convergence vital essence, promoting tissue regeneration and ulcer healing, loosening bowel to relieve constipation.
Radix Curcumae: regulating qi to disperse stagnation, heart fire-clearing upset-relieving, promoting the function of the gallbladder to alleviate jaundice.
Beneficial effect of the present invention: medicine of the present invention, channels sootheing and network vessel quickening is arranged, the effect of relieving spasm to stop pain is used for numb limbs and tense tendons, pain and limitation of activity that hyperosteogeny of cervical vertebra, cervical spondylosis cause, and effect is remarkable; And raw materials used medicine is Chinese medicine, and almost non-toxic side effect can relievedly eat.
The specific embodiment:
A kind of medicine of treating cervical spondylosis is prepared from following crude drug:
15 parts of the Radixs Astragali, 10 parts in Radix Glycyrrhizae, 10 parts of Radix Bupleuri, 10 parts in Herba Ephedrae, 10 parts of Rhizoma Chuanxiongs, 5 parts of Caulis Spatholobis, 5 parts on Flos Carthami, 5 parts of Radix Cynanchi Auriculatis, 5 parts of Radix Curcumaes.
Method for preparing: the above-mentioned raw materials medicine is weighed up by weight, and the water of putting into 10 times of weight boiled 2-4 hour, filtered out medicinal residues, and concentrated filtrate becomes dry extract, pulverized, and was pressed into tablet or processed capsule.
Clinical experiment
1, physical data
Among the 743 routine patients, male's 496 examples, women's 247 examples, men and women's ratio 2:1, sick time weak point person three months, elder reach 5～6 years.
, diagnostic criteria
All patients all make a definite diagnosis through X-ray photograph or CT examination, and combine patient's symptom analysis to make a definite diagnosis.
, clinical symptoms
In 743 routine patients, dizzy 188 examples account for 25.30%; Restriction of neck motion shoulder pain 234 examples account for 31.50%; Lower limb moving difficulty 13 examples account for 1.75%; Dizzy vomiting 17 examples account for 2.29%, and soft unable 78 examples of body account for 10.50%, and numbness of lower limbs 213 examples account for 28.66%.
, treatment rule and medication
According to the differentiation of tcm rule,,, adopt three months one courses of treatment of Drug therapy of pharmaceutical composition of the present invention with the method for channels sootheing and network vessel quickening, relieving spasm to stop pain in conjunction with the modern medicine scientific methods.
, criterion of therapeutical effect
Criterion of therapeutical effect is divided 4 grades: healing, produce effects, effective, invalid.
Effective percentage=(curing number+produce effects number+significant figure)/patient example number * 100%.
, therapeutic outcome:See the following form 1.
Table 1 Drug therapy cervical spondylosis of the present invention effect table
7, conclusion
Use checking through 743 routine patients, the total effective rate of treatment cervical spondylosis is 94.89%, explains that medicine of the present invention has significant curative effect to the treatment cervical spondylosis.
Claims (1)
1. medicine of treating cervical spondylosis is characterized in that being processed by following bulk drugs:
15 parts of the Radixs Astragali, 10 parts in Radix Glycyrrhizae, 10 parts of Radix Bupleuri, 10 parts in Herba Ephedrae, 10 parts of Rhizoma Chuanxiongs,
5 parts of Caulis Spatholobis, 5 parts on Flos Carthami, 5 parts of Radix Cynanchi Auriculatis, 5 parts of Radix Curcumaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100844336A CN102133380B (en) | 2011-04-06 | 2011-04-06 | Medicament for treating cervical spondylosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100844336A CN102133380B (en) | 2011-04-06 | 2011-04-06 | Medicament for treating cervical spondylosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102133380A CN102133380A (en) | 2011-07-27 |
| CN102133380B true CN102133380B (en) | 2012-03-28 |
Family
ID=44293393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011100844336A Active CN102133380B (en) | 2011-04-06 | 2011-04-06 | Medicament for treating cervical spondylosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102133380B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106983783A (en) * | 2016-01-18 | 2017-07-28 | 北京亚东生物制药有限公司 | It is a kind of for Chinese medicine composition of cervical spondylopathy and preparation method thereof |
| CN105797107A (en) * | 2016-04-19 | 2016-07-27 | 劳炳凤 | Medicine for treating cervical spondylosis |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101721664A (en) * | 2008-11-04 | 2010-06-09 | 王生 | Traditional Chinese medicine for treating apoplectic hemiplegia and general paralysis |
-
2011
- 2011-04-06 CN CN2011100844336A patent/CN102133380B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101721664A (en) * | 2008-11-04 | 2010-06-09 | 王生 | Traditional Chinese medicine for treating apoplectic hemiplegia and general paralysis |
Non-Patent Citations (1)
| Title |
|---|
| 苏国义等.神经根型颈椎病的古代文献认识.<<中国中医骨伤科杂志>>.2010,第18卷(第11期),60-62. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102133380A (en) | 2011-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101411802B (en) | Black plaster for treating hyperosteogeny and preparation method thereof | |
| CN100423761C (en) | Chinese medicinal preparation for treating fracture, traumatic injury | |
| CN1285196A (en) | Shubi plaster for treating arthralgia due to wind-cold-dampness | |
| CN104225508A (en) | Traditional Chinese medicine composition for cervical spondylosis treatment and preparation method thereof | |
| CN101549137A (en) | Chinese medicine preparation for treating bone joint disease | |
| CN102133380B (en) | Medicament for treating cervical spondylosis | |
| CN101721651B (en) | Traditional Chinese medicine capsule for treating scapulohumeral periarthritis | |
| CN101293041B (en) | Externally used medicament for treating protrusion of lumbar vertebral disc, spinal canal stenosis | |
| CN1391943A (en) | Chinese medicine paste for curing osteoarthropathy and preparing method | |
| CN105853969A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spinal stenosis and preparation method thereof | |
| CN106138436A (en) | A kind of Chinese medicine treating prolapse of lumbar intervertebral disc and hyperosteogeny and preparation method thereof | |
| CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN1241580C (en) | Medicinal composition for treating hypersteogeny | |
| CN103157072B (en) | Chinese medicinal composition for treating cervical spondylosis | |
| CN102327591B (en) | Phlegm-eliminating pill | |
| CN103520429A (en) | Traditional Chinese medicinal preparation used for treating rheumatic loin and leg pains | |
| CN103223012B (en) | External traditional Chinese medicine composition for treating sudden sprain in lumbar region and acute chest pain and preparation method thereof | |
| CN102614313A (en) | Externally applied Chinese medicine spray for curing scapulohumeral periarthritis | |
| CN100406035C (en) | Chinese medicine preparation for treating protrasion of lumbar intervertebral disc | |
| CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
| CN102125625A (en) | Traditional Chinese medicine for treating ankylosing spondylitis | |
| CN1772245A (en) | Snake medicinal wine for health care massage and its application | |
| CN106420999A (en) | Blood-activating decoction for treating joint degenerative changes | |
| CN101040980A (en) | Chinese traditional medicine compound for treating protrusion of lumbar intervertebral disc for external application | |
| CN104740431A (en) | Drug for treating cervical and lumbar diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU ZHAOJUN Free format text: FORMER OWNER: LI QIURONG Effective date: 20120117 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Liu Chaojun Inventor before: Li Qiurong |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250101 JINAN, SHANDONG PROVINCE TO: 272051 JINING, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LI QIURONG TO: LIU ZHAOJUN |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20120117 Address after: 272051 Shandong Province in Rencheng District of Jining City Li Ying Zhen Ji Dai Road No. 1 Jining city mental hospital Applicant after: Liu Chaojun Address before: Xindian garden Licheng District 250101 in Shandong province Ji'nan City No. 18 building 3 unit 702 room Applicant before: Li Qiurong |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: JIANGSU HANCHEN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LIU CHAOJUN Effective date: 20130701 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 272051 JINING, SHANDONG PROVINCE TO: 226132 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130701 Address after: 226132, three Bridge Road, Yue Yue Industrial Zone, Haimen, Jiangsu, Nantong 188, China Patentee after: Jiangsu Hanchen Pharmaceutical Co., Ltd. Address before: 272051 Shandong Province in Rencheng District of Jining City Li Ying Zhen Ji Dai Road No. 1 Jining city mental hospital Patentee before: Liu Chaojun |
|
| ASS | Succession or assignment of patent right |
Owner name: NANTONG YUEYUE INDUSTRY CO., LTD. Free format text: FORMER OWNER: JIANGSU HANCHEN PHARMACEUTICAL CO., LTD. Effective date: 20150702 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150702 Address after: 226131 Jiangsu city of Nantong Province Haimen Yuelai town Fuxing Road, building 12, the town government compound Patentee after: Nantong Yue Yue Industrial Co., Ltd. Address before: 226132, three Bridge Road, Yue Yue Industrial Zone, Haimen, Jiangsu, Nantong 188, China Patentee before: Jiangsu Hanchen Pharmaceutical Co., Ltd. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20181221 Address after: 226100 Fuxing Road, Yuet Lai Town, Haimen, Nantong, Jiangsu, 18 Patentee after: Haimen Zhi Zhou Industrial Design Co., Ltd. Address before: 226131 Government Courtyard, Building 12, Fuxing Road, Yuelai Town, Haimen City, Nantong City, Jiangsu Province Patentee before: Nantong Yue Yue Industrial Co., Ltd. |
|
| TR01 | Transfer of patent right |